Wiza logo
Wiza logo
Get a demo
Get started for free

Feridoun Karimi-Busheri - Email & Phone Number

Senior Investigator, Director of Stem Cell Department at Novarx Corporation

Feridoun Karimi-Busheri is based out of San Diego, California, United States and works at Novarx Corporation as Senior Investigator, Director of Stem Cell Department.

Feridoun Karimi-Busheri's Contact Information

Latest update
October 11, 2025
Location
San Diego, California, United States

Feridoun's current employer

Novarx Corporation logo

Novarx Corporation

Description
Get discounts on all your prescription medications. Save up to 75% at 65,000 Pharmacies Nationwide.
Website
novarx.com
HQ Location
California, United states
Number of employees
11-50
Industry
Pharmaceutical Manufacturing
Latest update
May 1, 2024

Frequent questions about Feridoun Karimi-Busheri

What company is Feridoun Karimi-Busheri working for?
Feridoun Karimi-Busheri works for Novarx Corporation.
What is Feridoun Karimi-Busheri's function at Novarx Corporation?
Feridoun Karimi-Busheri is Senior Investigator, Director of Stem Cell Department at Novarx Corporation.
Where is Feridoun Karimi-Busheri based?
Feridoun Karimi-Busheri is based out of San Diego, California, United States.
Who are Feridoun Karimi-Busheri's co-workers?
Feridoun Karimi-Busheri's colleagues are Steve Moses, Patricia Creighton, Terry Chamberlin, Habib Fakhrai.
Find anyone's contact info.
Get 20 free email reveals

Feridoun's co-workers

Steve Moses avatar
Steve Moses
V.P. Technical Operations
Patricia Creighton avatar
Patricia Creighton
Senior Manager, Head of Regulatory Affairs
Terry Chamberlin avatar
Terry Chamberlin
Director, Clinical Trials
Habib Fakhrai avatar
Habib Fakhrai
Chief Scientific Officer
Wiza does not guarantee or claim any of the information found on this public directory to be 100% accurate or up to date.Information found here is gathered from a variety of online and offline sources.If you wish to exclude your personal data from this public directory please fill out the optout form.